V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20028340 | 20012065 | 1.53 | 66.8 | Neo-adjuvant (N) | 2016-06-06 | 2016-06-17 | FEC + DOCETAXEL | 2 | N | 20099787 | FEC + DOCETAXEL |
| 20028341 | 20012065 | null | 67.95 | Adjuvant (A) | 2017-01-31 | 2017-02-15 | FEC 100 + DOCETAXEL | null | null | 20099787 | FEC + DOCETAXEL |
| 20028342 | 20012066 | null | 66 | null | 2013-07-01 | 2013-07-19 | FEC + DOCETAXEL | N | N | 20099796 | FEC + DOCETAXEL |
| 20028343 | 20012067 | 1.66 | 76.8 | Not known (9) | 2014-01-10 | 2014-01-10 | FEC 100 + DOCETAXEL | 2 | N | 20099797 | FEC + DOCETAXEL |
| 20028344 | 20012068 | 1.71 | 80.6 | Adjuvant (A) | 2013-04-06 | 2013-04-07 | FEC + DOCETAXEL | 2 | N | 20099798 | FEC + DOCETAXEL |
| 20028345 | 20012068 | 1.64 | 90 | Adjuvant (A) | 2016-08-09 | 2016-08-17 | FEC + DOCETAXEL | 02 | N | 20099798 | FEC + DOCETAXEL |
| 20028346 | 20012069 | 1.66 | null | Neo-adjuvant (N) | 2015-10-23 | 2015-10-23 | FEC + DOCETAXEL | null | null | 20099803 | FEC + DOCETAXEL |
| 20028347 | 20012070 | 1.65 | 70 | Neo-adjuvant (N) | 2014-04-11 | 2014-04-11 | FEC + DOCETAXEL | 2 | N | 20099805 | FEC + DOCETAXEL |
| 20028348 | 20012071 | 1.62 | 90.8 | Adjuvant (A) | 2016-09-30 | 2016-10-08 | FEC + DOCETAXEL | 2 | N | 20099807 | FEC + DOCETAXEL |
| 20028349 | 20012072 | 1.75 | null | Adjuvant (A) | 2016-04-16 | 2016-05-02 | FEC + DOCETAXEL | N | Y | 20099818 | FEC + DOCETAXEL |
| 20028350 | 20012072 | 1.77 | 86.6 | Adjuvant (A) | 2016-11-20 | 2016-11-26 | FEC 100 + DOCETAXEL | 02 | N | 20099818 | FEC + DOCETAXEL |
| 20028351 | 20012072 | 1.54 | 98 | Adjuvant (A) | 2016-04-06 | 2016-04-26 | FEC + DOCETAXEL | N | N | 20099818 | FEC + DOCETAXEL |
| 20028352 | 20012073 | 1.56 | 107.4 | Adjuvant (A) | 2013-12-11 | 2013-12-11 | FEC + DOCETAXEL | 02 | null | 20099828 | FEC + DOCETAXEL |
| 20028353 | 20012073 | null | null | Adjuvant (A) | 2016-03-09 | 2016-03-23 | FEC + DOCETAXEL | N | N | 20099828 | FEC + DOCETAXEL |
| 20028354 | 20012074 | 1.63 | 96.6 | null | 2018-01-06 | 2018-01-13 | FEC + DOCETAXEL | 99 | null | 20099835 | FEC + DOCETAXEL |
| 20028355 | 20012074 | 1.67 | 68 | Adjuvant (A) | 2017-02-13 | 2017-03-07 | FEC + DOCETAXEL | N | N | 20099835 | FEC + DOCETAXEL |
| 20028356 | 20012075 | 1.59 | 90.8 | Adjuvant (A) | 2016-11-15 | 2016-11-19 | FEC + DOCETAXEL | 02 | null | 20099837 | FEC + DOCETAXEL |
| 20028357 | 20012075 | 1.72 | 72.2 | Adjuvant (A) | 2017-02-11 | 2017-02-13 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20099837 | FEC + DOCETAXEL |
| 20028358 | 20012076 | 1.68 | 58.6 | Neo-adjuvant (N) | 2014-05-17 | 2014-05-17 | FEC 100 + DOCETAXEL | 02 | N | 20099840 | FEC + DOCETAXEL |
| 20028359 | 20012076 | null | 61.4 | Adjuvant (A) | 2017-09-04 | 2017-09-04 | FEC 100 + DOCETAXEL | 02 | N | 20099840 | FEC + DOCETAXEL |
| 20028360 | 20012076 | 1.66 | 70.7 | Adjuvant (A) | 2015-06-12 | 2015-06-29 | FEC 100 + DOCETAXEL | 02 | null | 20099840 | FEC + DOCETAXEL |
| 20028361 | 20012076 | 1.57 | null | Adjuvant (A) | 2016-08-18 | 2016-08-18 | FEC + DOCETAXEL | N | N | 20099840 | FEC + DOCETAXEL |
| 20028362 | 20012076 | 1.62 | 68 | Neo-adjuvant (N) | 2013-05-28 | 2013-05-28 | FEC + DOCETAXEL | 02 | null | 20099840 | FEC + DOCETAXEL |
| 20028363 | 20012076 | 1.6 | 66.8 | Not known (9) | null | 2015-02-05 | FEC + DOCETAXEL | null | null | 20099840 | FEC + DOCETAXEL |
| 20028364 | 20012076 | 1.56 | 62.1 | Adjuvant (A) | 2015-03-23 | 2015-05-13 | FEC 100 + DOCETAXEL | 2 | N | 20099840 | FEC + DOCETAXEL |
| 20028365 | 20012077 | 1.61 | 60.5 | Neo-adjuvant (N) | 2015-02-21 | 2015-02-21 | FEC + DOCETAXEL | 02 | N | 20099865 | FEC + DOCETAXEL |
| 20028366 | 20012077 | null | null | Neo-adjuvant (N) | 2016-03-26 | 2016-04-04 | FEC + DOCETAXEL | 99 | null | 20099865 | FEC + DOCETAXEL |
| 20028367 | 20012078 | 1.61 | 72.3 | Neo-adjuvant (N) | 2014-02-28 | 2014-03-02 | FEC 100 + DOCETAXEL | 2 | N | 20099874 | FEC + DOCETAXEL |
| 20028368 | 20012078 | 1.74 | 51.4 | Adjuvant (A) | 2014-07-13 | 2014-07-19 | FEC + DOCETAXEL | 2 | N | 20099874 | FEC + DOCETAXEL |
| 20028369 | 20012078 | 1.72 | 46.5 | Adjuvant (A) | 2016-07-06 | 2016-07-06 | FEC 100 + DOCETAXEL | 02 | N | 20099874 | FEC + DOCETAXEL |
| 20028370 | 20012079 | null | 67.1 | Neo-adjuvant (N) | 2017-11-07 | 2017-11-07 | FEC + DOCETAXEL | N | N | 20099885 | FEC + DOCETAXEL |
| 20028371 | 20012080 | 1.63 | 79.6 | Adjuvant (A) | 2015-03-10 | 2015-03-10 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | null | 20099887 | FEC + DOCETAXEL |
| 20028372 | 20012080 | 1.67 | 63.4 | Adjuvant (A) | 2015-05-09 | 2015-05-23 | FEC + DOCETAXEL | N | N | 20099887 | FEC + DOCETAXEL |
| 20028373 | 20012081 | 1.67 | 57 | Adjuvant (A) | 2017-03-10 | 2017-03-10 | FEC + DOCETAXEL | 02 | N | 20099893 | FEC + DOCETAXEL |
| 20028374 | 20012081 | 1.54 | 66.8 | Adjuvant (A) | 2013-05-09 | 2013-05-22 | FEC + DOCETAXEL | 02 | N | 20099893 | FEC + DOCETAXEL |
| 20028375 | 20012082 | 1.6 | 64 | Neo-adjuvant (N) | null | 2016-11-30 | FEC + DOCETAXEL | N | N | 20099897 | FEC + DOCETAXEL |
| 20028376 | 20012082 | 1.62 | 107.4 | Adjuvant (A) | null | 2016-01-21 | FEC 100 + DOCETAXEL | N | N | 20099897 | FEC + DOCETAXEL |
| 20028377 | 20012083 | 1.53 | 76.8 | Adjuvant (A) | 2017-09-27 | 2017-10-04 | FEC + DOCETAXEL | 02 | N | 20099901 | FEC + DOCETAXEL |
| 20028378 | 20012083 | 1.58 | 84 | Adjuvant (A) | 2016-07-01 | 2016-07-15 | FEC + DOCETAXEL | N | N | 20099901 | FEC + DOCETAXEL |
| 20028379 | 20012084 | 1.58 | 90.8 | Adjuvant (A) | 2016-05-06 | 2016-05-25 | FEC + DOCETAXEL | N | N | 20099906 | FEC + DOCETAXEL |
| 20028380 | 20012085 | null | 69.2 | Neo-adjuvant (N) | 2016-06-15 | 2016-06-23 | FEC + DOCETAXEL | N | N | 20099907 | FEC + DOCETAXEL |
| 20028381 | 20012086 | 1.57 | 78.7 | Curative (C) | 2014-09-04 | 2014-09-27 | FEC 100 + DOCETAXEL | N | N | 20099908 | FEC + DOCETAXEL |
| 20028382 | 20012086 | null | null | Neo-adjuvant (N) | 2015-02-12 | 2015-03-05 | FEC + DOCETAXEL | N | N | 20099908 | FEC + DOCETAXEL |
| 20028383 | 20012086 | 1.62 | 90.2 | Neo-adjuvant (N) | 2017-11-25 | 2017-11-26 | FEC 100 + DOCETAXEL | 02 | N | 20099908 | FEC + DOCETAXEL |
| 20028384 | 20012086 | 1.57 | 55.1 | Adjuvant (A) | 2018-01-14 | 2018-01-29 | FEC + DOCETAXEL | 02 | N | 20099908 | FEC + DOCETAXEL |
| 20028385 | 20012087 | null | null | Adjuvant (A) | 2016-05-20 | 2016-06-09 | FEC 100 + DOCETAXEL | null | null | 20099931 | FEC + DOCETAXEL |
| 20028386 | 20012087 | 1.72 | null | Adjuvant (A) | 2017-07-24 | 2017-08-07 | FEC + DOCETAXEL | N | N | 20099931 | FEC + DOCETAXEL |
| 20028387 | 20012088 | 1.61 | null | Adjuvant (A) | 2014-04-20 | 2014-05-18 | FEC + DOCETAXEL | N | N | 20099938 | FEC + DOCETAXEL |
| 20028388 | 20012088 | 1.63 | 78 | Adjuvant (A) | 2013-02-20 | 2013-02-27 | FEC + DOCETAXEL | 2 | null | 20099938 | FEC + DOCETAXEL |
| 20028389 | 20012089 | 1.66 | 82.5 | Adjuvant (A) | 2016-07-20 | 2016-07-26 | FEC + DOCETAXEL | 02 | N | 20099942 | FEC + DOCETAXEL |